# Hypofraction Radiotherapy for Limited-Stage Small Cell Lung Cancer

> **NCT05523908** · NA · COMPLETED · sponsor: **Anhui Provincial Hospital** · enrollment: 40 (actual)

## Conditions studied

- Safety Issues
- Efficacy, Self

## Interventions

- **RADIATION:** High-dose hypofraction Arm
- **RADIATION:** Low-dose hypofraction Arm (Standard BED)

## Key facts

- **NCT ID:** NCT05523908
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-01
- **Primary completion:** 2023-08-31
- **Final completion:** 2024-08-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05523908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05523908, "Hypofraction Radiotherapy for Limited-Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT05523908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*